Previous 10 |
SEATTLE, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the virtual Morgan Stan...
Markets are at records despite the Covid crisis, and tech in particular is an investor darling. And those conditions may be creating a sweet spot for a slew of new companies to go public. More news on: SPDR S&P 500 Trust ETF, Invesco QQQ ETF, Zoom Video Communications, Inc., , News on ...
Accolade ( ACCD ) has been on my watch list after I concluded early July that this was an interesting tech and healthcare offering when I looked at the investment thesis when the company went public. The company has just reported its first-quarter results which were slightly better than ...
The following slide deck was published by Accolade, Inc. in conjunction with their 2021 Q1 earnings Read more ...
Accolade, Inc. (ACCD) Q1 2021 Earnings Conference Call August 13, 2020 5:00 PM ET Company Participants Rajeev Singh – Chief Executive Officer Steve Barnes – Chief Financial Officer Conference Call Participants Bob Jones – Goldman Sachs Ricky Goldwasser ...
Accolade (NASDAQ: ACCD ) : Q1 GAAP EPS of -$1.86 misses by $1.49 . Revenue of $35.9M (+24.7% Y/Y) beats by $1.76M . Shares +0.54% . Press Release More news on: Accolade, Inc., Earnings news and commentary, Tech stocks news,
Fiscal first quarter 2021 revenue of $35.9 million, a 25% increase compared to fiscal first quarter 2020 revenue of $28.8 million, driven primarily by strength in new customer adds across segments and offerings Launched pilot with Defense Health Agency, our first customer in the feder...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...